FIRST INTERNATIONAL CONFERENCE ON TRANSLATIONAL RESEARCH
首届国际转化研究会议
基本信息
- 批准号:6153454
- 负责人:
- 金额:$ 1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-03-03 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The "First International Conference on Translational Research and Pre-Clinical Strategies in Radio-Oncology" (ICTR 2000) will be organized in Lugano, Switzerland, from March 5 till March 8, 2000. The Conference is sponsored and planned as a joint effort by an independent organization with members from a number of countries. These doctors and scientists are involved in research and health care activities related to radiation sciences and are leading major Oncology Institutions in their country. The members of the Organizing Committee pertain to the three main disciplines of Radio-Oncology: radiation physicists, radio-biologists and clinicians. It is planned that the Conference will be organized every three years. The organization of the Conference on Translational Research results from the great expectation, in the oncology community, for a real mutation in clinical radiotherapy, as well as from the need for addressing more formally the strong links between new technologies, biological/chemical tools, and prospective clinical investigations. Trying to conform to the changing relationships between research and clinical application in Radiation Oncology, the emphasis of the Conference is the individualization of cancer treatment. Education will be one of the major features of this first International Conference, especially through Forum sessions, Debates, Workshops and Symposia, which will give chairmen and speakers an opportunity to promote discussion between senior staff members and young scientists willing to expand their knowledge on "from bench to bedside" research. The target is to gather more than 600 participants, with an expected 50 percent proportion of U.S. biologists, physicists and oncologists.
第一届放射肿瘤学转化研究和临床前战略国际会议(ICTR 2000)将于2000年3月5日至8日在瑞士卢加诺举行。 该会议是由一个成员来自若干国家的独立组织共同赞助和规划的。 这些医生和科学家参与了与放射科学相关的研究和医疗保健活动,并在他们的国家领导主要的肿瘤学机构。 组织委员会的成员属于放射肿瘤学的三个主要学科:放射物理学家,放射生物学家和临床医生。 计划每三年举行一次会议。转化研究会议的组织源于肿瘤学界对临床放射治疗中真实的突变的巨大期望,以及更正式地解决新技术,生物/化学工具和前瞻性临床研究之间的紧密联系的需要。为了顺应放射肿瘤学研究和临床应用之间不断变化的关系,会议的重点是癌症治疗的个体化。教育将是第一次国际会议的主要特点之一,特别是通过论坛会议、辩论、讲习班和专题讨论会,这将使主席和发言者有机会促进高级工作人员和愿意扩大“从实验室到床边”研究知识的年轻科学家之间的讨论。 目标是聚集600多名参与者,其中50%是美国生物学家、物理学家和肿瘤学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM G. MCKENNA其他文献
WILLIAM G. MCKENNA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM G. MCKENNA', 18)}}的其他基金
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6616903 - 财政年份:2002
- 资助金额:
$ 1万 - 项目类别:
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6470075 - 财政年份:2001
- 资助金额:
$ 1万 - 项目类别:
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6318316 - 财政年份:2000
- 资助金额:
$ 1万 - 项目类别:
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6323310 - 财政年份:2000
- 资助金额:
$ 1万 - 项目类别:
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6103386 - 财政年份:1999
- 资助金额:
$ 1万 - 项目类别:
RAS SIGNAL TRANSDUCTION IN CELL CYCLE RESPONSE TO RADIATION
细胞周期辐射反应中的 RAS 信号转导
- 批准号:
6300567 - 财政年份:1999
- 资助金额:
$ 1万 - 项目类别:
CELL CYCLE TARGETS FOR DRUG AND RADIATION SENSITIVITY
药物和辐射敏感性的细胞周期目标
- 批准号:
2686768 - 财政年份:1998
- 资助金额:
$ 1万 - 项目类别:
CELL CYCLE TARGETS FOR DRUG AND RADIATION SENSITIVITY
药物和辐射敏感性的细胞周期目标
- 批准号:
6159304 - 财政年份:1998
- 资助金额:
$ 1万 - 项目类别:
CELL CYCLE TARGETS FOR DRUG AND RADIATION SENSITIVITY
药物和辐射敏感性的细胞周期目标
- 批准号:
2896096 - 财政年份:1998
- 资助金额:
$ 1万 - 项目类别:














{{item.name}}会员




